Elevated Hyaluronan Levels in Patients with Rheumatic Mitral Stenosis and Pulmonary Arterial Thromboembolism


KALAY N. , ELÇİK D. , Savas G. , Altın P., Sakalar C., Kaya O., ...More

HEART LUNG AND CIRCULATION, vol.23, no.7, pp.649-654, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 7
  • Publication Date: 2014
  • Doi Number: 10.1016/j.hlc.2014.01.011
  • Title of Journal : HEART LUNG AND CIRCULATION
  • Page Numbers: pp.649-654

Abstract

Introduction: The role of hyaluronan (HA) was previously demonstrated in patients with idiopathic pulmonary arterial hypertension (PAH). Mitral stenosis (MS) and pulmonary arterial thromboembolism (PTE) are important health problems that can cause pulmonovascular pathology. Pulmonary arterial hypertension develops especially in untreated patients with severe MS and most of patients with PTE. However, there is no data about HA levels in patients with MS and PTE. In this study, we investigated HA levels in patients with rheumatic MS and PTE.